Discovering The Potential Role of LRIC4 in Drug Discovery and Treatment

Target Name: LRRIQ4

NCBI ID: G344657

LRRIQ4

Discovering The Potential Role of LRIC4 in Drug Discovery and Treatment

LRRIQ4 (LRRC64) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the LDL receptor-related intracellular signaling (LRIC) family, which is known for its role in Regulating cellular signaling pathways. Members of the LRIC family play important roles in multiple fields such as cell signaling, metabolism, and immunology. In recent years, scientists have discovered that members of the LRIC family play important roles in many diseases, including neurological diseases, cardiovascular diseases, and kidney diseases. Therefore, studying the potential role of members of the LRIC family in drug discovery and treatment is of great clinical significance.

Role and function of LRRIQ4

The role of LRRIQ4 in cell signaling is mainly reflected in regulating the insulin signaling pathway. Insulin signaling is an important metabolic regulatory process within cells. In insulin signaling, after the insulin receptor binds to insulin, it initiates a series of signaling pathways to regulate intracellular metabolic activities. Members of the LRIC family are signaling molecules that play a key role in this process.

LRRIQ4 can inhibit 尾2 kinase (PYK4) in the insulin signaling pathway by binding to the insulin receptor. 尾2 kinase is a key enzyme in the insulin signaling pathway. It can phosphorylate the insulin receptor, thereby reducing its binding ability. The inhibition of LRRIQ4 weakens intracellular insulin signaling, thereby weakening the regulation of cellular metabolism. This discovery provides a new idea for treating diabetes: By inhibiting members of the LRIC family, insulin signaling can be slowed down, thereby lowering blood sugar levels.

In addition, LRRIQ4 is also involved in many important biological processes, including cell proliferation, differentiation, and tumor formation. During these processes, members of the LRIC family can regulate cell growth and differentiation, thereby having an important impact on the development and regeneration of tissues and organs.

Biological functions and drug targets of LRRIQ4

Since members of the LRIC family play important roles in cell signaling, metabolism, and tumor formation, they are widely considered as drug targets. In recent years, scientists have discovered many drug targets related to the LRIC family. These drug targets include insulin receptors, glucose transporters, intracellular transport proteins, etc.

Currently, LRRIQ4, a member of the LRIC family, has become the focus of many drug studies. For example, scientists have discovered that LRIC4 is a potential drug target that can be used to treat a variety of neurological diseases, including Parkinson's disease, Alzheimer's disease, and depression. In addition, LRIC4 is also used to treat a variety of cardiovascular diseases, including myocardial infarction, stroke, and hypertension.

in conclusion

LRRIQ4 is a protein that plays an important role in cell signaling, metabolism, and tumor formation. In recent years, scientists have identified LRIC4 as a potential drug target for the treatment of a variety of neurological and cardiovascular diseases. Further research will help to deeply explore the potential role of members of the LRIC family in drug discovery and treatment, bringing more hope to human health.

Protein Name: Leucine Rich Repeats And IQ Motif Containing 4

The "LRRIQ4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRIQ4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets